{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:35:07Z","timestamp":1791902107862,"version":"4.3.4"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":262,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Pharmacology and Drug Discovery"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.crphar.2021.100058","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T12:01:40Z","timestamp":1632744100000},"page":"100058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Host directed therapies: COVID-19 and beyond"],"prefix":"10.1016","volume":"2","author":[{"given":"Devavrat","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Sodani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crphar.2021.100058_bib1","first-page":"891","article-title":"The Middle East respiratory syndrome (MERS)","volume":"33","author":"Azhar","year":"2019","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.crphar.2021.100058_bib2","first-page":"100084","article-title":"A\u00a0randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: a broad spectrum antiviral candidate for treatment of COVID-19. The Lancet regional health","volume":"4","author":"Backer","year":"2021","journal-title":"Europe"},{"key":"10.1016\/j.crphar.2021.100058_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI46465","article-title":"The intersection of genetic and chemical genomic screens identifies GSK-3\u03b1 as a target in human acute myeloid leukemia","volume":"122","author":"Banerji","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.crphar.2021.100058_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12955-019-1165-2","article-title":"Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)","volume":"17","author":"Batawi","year":"2019","journal-title":"Health Qual. Life Outcome"},{"key":"10.1016\/j.crphar.2021.100058_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/jir.2009.0075","article-title":"Human papillomaviruses and the interferon response","volume":"29","author":"Beglin","year":"2009","journal-title":"J.\u00a0Interferon Cytokine Res. : the official journal of the International Society for Interferon and Cytokine Research"},{"key":"10.1016\/j.crphar.2021.100058_bib6","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.crphar.2021.100058_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","article-title":"Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase Ib\/IIa study","volume":"65","author":"Bogomolov","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.crphar.2021.100058_bib8","volume":"vol. 9","author":"Bojkova","year":"2020"},{"key":"10.1016\/j.crphar.2021.100058_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","article-title":"Proteomics of SARS-CoV-2-infected host cells reveals therapy targets","volume":"583","author":"Bojkova","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2021.100058_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ebiom.2015.07.041","article-title":"Human exportin-1 is a target for combined therapy of HIV and AIDS related lymphoma","volume":"2","author":"Boons","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.crphar.2021.100058_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02186","article-title":"Common nodes of virus-host interaction revealed through an integrated network analysis","volume":"10","author":"B\u00f6sl","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crphar.2021.100058_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/2049-632X.12053","article-title":"Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium","volume":"69","author":"B\u00f6ttcher-Friebertsh\u00e4user","year":"2013","journal-title":"Pathogens and disease"},{"key":"10.1016\/j.crphar.2021.100058_bib13","article-title":"Pathway-based analysis of genome-wide siRNA screens reveals the regulatory landscape of APP processing","volume":"10","author":"Camargo","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.crphar.2021.100058_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2018.10.007","article-title":"The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K\/Akt pathway and protects Zika virus-infected A129 mice: a host-targeting treatment strategy","volume":"160","author":"Chan","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib16","article-title":"Variations in genome-wide RNAi screens: lessons from influenza research","volume":"5","author":"Chou","year":"2015","journal-title":"J.\u00a0Clin. Bioinf."},{"key":"10.1016\/j.crphar.2021.100058_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004058","article-title":"Proteasome inhibition suppresses dengue virus egress in antibody dependent infection","volume":"9","author":"Choy","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.crphar.2021.100058_bib18","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1073\/pnas.110149597","article-title":"Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways","volume":"97","author":"Clemens","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.crphar.2021.100058_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13091","article-title":"Successful treatment of hepatitis C virus infection with direct-acting antivirals during hematopoietic cell transplant","volume":"21","author":"Cunningham","year":"2019","journal-title":"Transpl. Infect. Dis. : an official journal of the Transplantation Society"},{"key":"10.1016\/j.crphar.2021.100058_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-014-0115-1","article-title":"Virus-host interactomics: new insights and opportunities for antiviral drug discovery","volume":"6","author":"de Chassey","year":"2014","journal-title":"Genome Med."},{"key":"10.1016\/j.crphar.2021.100058_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.crphar.2021.100058_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101755","article-title":"An update on SARS-CoV-2\/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies","volume":"37","author":"Dhama","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.crphar.2021.100058_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J.\u00a0Health Econ."},{"key":"10.1016\/j.crphar.2021.100058_bib24","series-title":"The Natural Compound Homoharringtonine Presents Broad Antiviral Activity in Vitro and in Vivo","author":"Dong","year":"2018"},{"key":"10.1016\/j.crphar.2021.100058_bib25","volume":"vol. 13","author":"Dong","year":"2019"},{"key":"10.1016\/j.crphar.2021.100058_bib26","doi-asserted-by":"crossref","first-page":"104651","DOI":"10.1016\/j.antiviral.2019.104651","article-title":"Receptor tyrosine kinase inhibitors block proliferation of TGEV mainly through p38 mitogen-activated protein kinase pathways","volume":"173","author":"Dong","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib27","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crphar.2021.100058_bib28","doi-asserted-by":"crossref","first-page":"26915","DOI":"10.1073\/pnas.2001046117","article-title":"Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection","volume":"117","author":"Edwards","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.crphar.2021.100058_bib29","first-page":"649","article-title":"Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study. The lancet","volume":"5","author":"Feld","year":"2020","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.crphar.2021.100058_bib30","first-page":"911","article-title":"Cyclophilin inhibitors for the treatment of HCV infection","volume":"11","author":"Fischer","year":"2010","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.crphar.2021.100058_bib31","volume":"vol. 13","author":"Franco","year":"2021"},{"key":"10.1016\/j.crphar.2021.100058_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35042517","article-title":"Functional genomic analysis of C. elegans chromosome I by systematic RNA interference","volume":"408","author":"Fraser","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2021.100058_bib33","doi-asserted-by":"crossref","first-page":"100763","DOI":"10.1016\/j.bbrep.2020.100763","article-title":"EGF receptor inhibitors comprehensively suppress hepatitis B virus by downregulation of STAT3 phosphorylation","volume":"22","author":"Gan","year":"2020","journal-title":"Biochemistry and Biophysics Reports"},{"key":"10.1016\/j.crphar.2021.100058_bib34","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1128\/JVI.00718-13","article-title":"MicroRNA 181 suppresses porcine reproductive and respiratory syndrome virus (PRRSV) infection by targeting PRRSV receptor CD163","volume":"87","author":"Gao","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crphar.2021.100058_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fphys.2019.00425","article-title":"Experimental analysis of viral-host interactions","volume":"10","author":"Gillen","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.crphar.2021.100058_bib36","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.1073\/pnas.1017496108","article-title":"An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt\/<em>wingless<\/em> signaling pathway","volume":"108","author":"Gonsalves","year":"2011","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.crphar.2021.100058_bib37","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with covid-19","volume":"384","author":"Gordon","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.crphar.2021.100058_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A\u00a0SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2021.100058_bib39","volume":"vol. 12","author":"Goulding","year":"2020"},{"key":"10.1016\/j.crphar.2021.100058_bib40","doi-asserted-by":"crossref","first-page":"104187","DOI":"10.1016\/j.cellimm.2020.104187","article-title":"New disease old vaccine: is recombinant BCG vaccine an answer for COVID-19?","volume":"356","author":"Gupta","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.crphar.2021.100058_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","article-title":"Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19","volume":"181","author":"Gupta","year":"2021","journal-title":"JAMA internal medicine"},{"key":"10.1016\/j.crphar.2021.100058_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.antiviral.2011.07.006","article-title":"Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses","volume":"91","author":"Haasbach","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib43","first-page":"718","volume":"vol. 369","author":"Hadjadj","year":"2020"},{"key":"10.1016\/j.crphar.2021.100058_bib44","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.celrep.2018.03.045","article-title":"Genome-wide CRISPR\/Cas9 screen identifies host factors essential for influenza virus replication","volume":"23","author":"Han","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.crphar.2021.100058_bib45","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3026(15)00224-0","article-title":"Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis","volume":"3","author":"Hashmi","year":"2016","journal-title":"The Lancet. Haematology"},{"key":"10.1016\/j.crphar.2021.100058_bib46","series-title":"Silvestrol Inhibits Chikungunya Virus Replication. Viruses 10","author":"Henss","year":"2018"},{"key":"10.1016\/j.crphar.2021.100058_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chom.2010.12.001","article-title":"Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E","volume":"9","author":"Ho","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.crphar.2021.100058_bib48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.crphar.2021.100058_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.crphar.2021.100058_bib50","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"The Lancet. Rheumatology"},{"key":"10.1016\/j.crphar.2021.100058_bib51","first-page":"869","article-title":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features","volume":"33","author":"Hui","year":"2019","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.crphar.2021.100058_bib52","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/cid\/ciz949","article-title":"Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: current incidence rates, compared with rates during the interferon era","volume":"71","author":"Ingiliz","year":"2020","journal-title":"Clin. Infect. Dis. : an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.crphar.2021.100058_bib53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/v11090837","article-title":"The proteolytic regulation of virus cell entry by furin and other proprotein convertases","volume":"11","author":"Izaguirre","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.crphar.2021.100058_bib54","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.crphar.2021.100058_bib55","doi-asserted-by":"crossref","first-page":"922","DOI":"10.15252\/msb.20167062","article-title":"Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases","volume":"13","author":"Jean Beltran","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.crphar.2021.100058_bib56","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1038\/s41598-019-45095-1","article-title":"Neutralization of acidic intracellular vesicles by niclosamide inhibits multiple steps of the dengue virus life cycle in vitro","volume":"9","author":"Jung","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crphar.2021.100058_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.crphar.2021.100058_bib58","doi-asserted-by":"crossref","first-page":"13330","DOI":"10.1128\/JVI.02101-13","article-title":"Cyclophilin A binds to the viral RNA and replication proteins, resulting in inhibition of tombusviral replicase assembly","volume":"87","author":"Kovalev","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crphar.2021.100058_bib59","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/JVI.01969-10","article-title":"Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication","volume":"85","author":"Kumar","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crphar.2021.100058_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00168-19","article-title":"Host-directed antiviral therapy","volume":"33","author":"Kumar","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.crphar.2021.100058_bib61","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.crphar.2021.100058_bib62","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2010.11.006","article-title":"Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa)","volume":"89","author":"Langhammer","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib63","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16485","article-title":"Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe coronavirus disease 2019 (COVID-19)","volume":"3","author":"Laterre","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.crphar.2021.100058_bib64","series-title":"Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose. Viruses 11","author":"LeCher","year":"2019"},{"key":"10.1016\/j.crphar.2021.100058_bib65","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging and disease"},{"key":"10.1016\/j.crphar.2021.100058_bib66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41467-019-13965-x","article-title":"Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crphar.2021.100058_bib67","first-page":"99","article-title":"Virus-host interactome and proteomic Survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis","volume":"2","author":"Li","year":"2021","journal-title":"Med (New York, N.Y.)"},{"key":"10.1016\/j.crphar.2021.100058_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/prca.201400101","article-title":"Proteomics in the investigation of HIV-1 interactions with host proteins","volume":"9","author":"Li","year":"2015","journal-title":"Proteonomics Clin. Appl."},{"key":"10.1016\/j.crphar.2021.100058_bib69","doi-asserted-by":"crossref","first-page":"16410","DOI":"10.1073\/pnas.0907439106","article-title":"A\u00a0genome-wide genetic screen for host factors required for hepatitis C virus propagation","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.crphar.2021.100058_bib70","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1159\/000495897","article-title":"Type I interferons: distinct biological activities and current applications for viral infection","volume":"51","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem. : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"10.1016\/j.crphar.2021.100058_bib71","doi-asserted-by":"crossref","first-page":"9527","DOI":"10.1073\/pnas.1900867116","article-title":"Genome-wide CRISPR screen for Zika virus resistance in human neural cells","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.crphar.2021.100058_bib72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.celrep.2017.09.030","article-title":"Host MicroRNAs-221 and -222 inhibit HIV-1 entry in macrophages by targeting the CD4 viral receptor","volume":"21","author":"Lodge","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.crphar.2021.100058_bib73","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/14789450.2016.1147353","article-title":"Proteomic approaches to uncovering virus-host protein interactions during the progression of viral infection","volume":"13","author":"Lum","year":"2016","journal-title":"Expet Rev. Proteonomics"},{"key":"10.1016\/j.crphar.2021.100058_bib74","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.coviro.2012.09.003","article-title":"Virus-host interactomes--antiviral drug discovery","volume":"2","author":"Ma-Lauer","year":"2012","journal-title":"Current opinion in virology"},{"key":"10.1016\/j.crphar.2021.100058_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104620","article-title":"Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication","volume":"173","author":"Ma-Lauer","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib76","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.crphar.2021.100058_bib77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nature18631","article-title":"Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens","volume":"535","author":"Marceau","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2021.100058_bib78","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-018-0570-1","article-title":"A\u00a0genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle","volume":"10","author":"Martin","year":"2018","journal-title":"Genome Med."},{"key":"10.1016\/j.crphar.2021.100058_bib79","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.omtn.2017.03.008","article-title":"Broad-spectrum inhibition of respiratory virus infection by MicroRNA mimics targeting p38 MAPK signaling. Molecular therapy","volume":"7","author":"McCaskill","year":"2017","journal-title":"Nucleic acids"},{"key":"10.1016\/j.crphar.2021.100058_bib80","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-021-01282-0","article-title":"Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases","volume":"27","author":"Meganck","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.crphar.2021.100058_bib81","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A\u00a0SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.crphar.2021.100058_bib82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Monk","year":"2021","journal-title":"The Lancet. Respiratory medicine"},{"key":"10.1016\/j.crphar.2021.100058_bib83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mehy.2017.03.016","article-title":"Hepatitis C virus may have an entero-hepatic cycle which could be blocked with ezetimibe","volume":"102","author":"Monrroy","year":"2017","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.crphar.2021.100058_bib84","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1440-1843.2010.01720.x","article-title":"The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status","volume":"15","author":"Ngai","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.crphar.2021.100058_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.410","article-title":"Cyclophilin A: a key player for human disease","volume":"4","author":"Nigro","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.crphar.2021.100058_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007390","article-title":"Toll-like receptor 4 in acute viral infection: too much of a good thing","volume":"14","author":"Olejnik","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.crphar.2021.100058_bib87","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.copbio.2006.06.006","article-title":"Yeast two-hybrid contributions to interactome mapping","volume":"17","author":"Parrish","year":"2006","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.crphar.2021.100058_bib88","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tim.2010.07.003","article-title":"Epigenetic reprogramming of host genes in viral and microbial pathogenesis","volume":"18","author":"Paschos","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.crphar.2021.100058_bib89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2021.01.016","article-title":"Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies","volume":"86","author":"Pasin","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.crphar.2021.100058_bib90","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1128\/JVI.01774-14","article-title":"Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo","volume":"88","author":"Perwitasari","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crphar.2021.100058_bib91","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.antiviral.2017.10.014","article-title":"Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus","volume":"147","author":"Pitts","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib92","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/AAC.00189-09","article-title":"Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein","volume":"53","author":"Qing","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crphar.2021.100058_bib93","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41182-017-0072-7","article-title":"Identification of novel antiviral of fungus-derived brefeldin A against dengue viruses","volume":"45","author":"Raekiansyah","year":"2017","journal-title":"Trop. Med. Health"},{"key":"10.1016\/j.crphar.2021.100058_bib94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2021.100058_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006305","article-title":"miR-144 attenuates the host response to influenza virus by targeting the TRAF6-IRF7 signaling axis","volume":"13","author":"Rosenberger","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.crphar.2021.100058_bib96","series-title":"Virus Life Cycle. Molecular Virology of Human Pathogenic Viruses","first-page":"31","author":"Ryu","year":"2017"},{"key":"10.1016\/j.crphar.2021.100058_bib97","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1038\/s41467-020-17189-2","article-title":"Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing","volume":"11","author":"Sadegh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crphar.2021.100058_bib98","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0034-1368583","article-title":"Genistein as antiviral drug against HIV ion channel","volume":"80","author":"Sauter","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.crphar.2021.100058_bib99","series-title":"Chasing Intracellular Zika Virus Using Proteomics. Viruses 11","author":"Scaturro","year":"2019"},{"key":"10.1016\/j.crphar.2021.100058_bib100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41564-020-00846-z","article-title":"The SARS-CoV-2 RNA\u2013protein interactome in infected human cells","volume":"6","author":"Schmidt","year":"2021","journal-title":"Nature Microbiology"},{"key":"10.1016\/j.crphar.2021.100058_bib101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2018.07.006","article-title":"The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression","volume":"157","author":"Schr\u00e4der","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib102","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1073\/pnas.1112263109","article-title":"Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex","volume":"109","author":"Shimakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.crphar.2021.100058_bib103","volume":"vol. 15","author":"Smith","year":"2017"},{"key":"10.1016\/j.crphar.2021.100058_bib104","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02388-16","article-title":"A\u00a0MicroRNA screen identifies the wnt signaling pathway as a regulator of the interferon response during flavivirus infection","volume":"91","author":"Smith","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crphar.2021.100058_bib105","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1038\/s41598-021-88886-1","article-title":"Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo","volume":"11","author":"Song","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crphar.2021.100058_bib106","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1038\/s41598-021-88886-1","article-title":"Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo","volume":"11","author":"Song","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crphar.2021.100058_bib107","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.crphar.2021.100058_bib108","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41467-020-14978-7","article-title":"A\u00a0high-content RNAi screen reveals multiple roles for long noncoding RNAs in cell division","volume":"11","author":"Stojic","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crphar.2021.100058_bib109","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-021-03493-4","article-title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV","volume":"594","author":"Stukalov","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2021.100058_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020532","article-title":"Mapping the SARS-CoV-2-host protein-protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: a rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics","volume":"22","author":"Terracciano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crphar.2021.100058_bib111","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2018.07.010","article-title":"The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo","volume":"157","author":"Todt","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib112","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejphar.2017.05.038","article-title":"New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections","volume":"809","author":"van de Wakker","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.crphar.2021.100058_bib113","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response","volume":"217","author":"Vardhana","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.crphar.2021.100058_bib114","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1586\/14789450.4.6.815","article-title":"Viral proteomics: global evaluation of viruses and their interaction with the host","volume":"4","author":"Viswanathan","year":"2007","journal-title":"Expet Rev. Proteonomics"},{"key":"10.1016\/j.crphar.2021.100058_bib115","first-page":"2020.2009","article-title":"Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses","author":"Wang","year":"2020","journal-title":"bioRxiv : the preprint server for biology"},{"key":"10.1016\/j.crphar.2021.100058_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/v8030071","article-title":"The iminosugar UV-4 is a broad inhibitor of influenza A and B viruses ex vivo and in mice","volume":"8","author":"Warfield","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.crphar.2021.100058_bib117","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/v8030071","article-title":"The iminosugar UV-4 is a broad inhibitor of influenza A and B viruses ex vivo and in mice","volume":"8","author":"Warfield","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.crphar.2021.100058_bib118","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","article-title":"Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection","volume":"184","author":"Wei","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.crphar.2021.100058_bib119","series-title":"Genome-wide CRISPR Screen Reveals Host Genes that Regulate SARS-CoV-2 Infection","author":"Wei","year":"2020"},{"key":"10.1016\/j.crphar.2021.100058_bib120","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1128\/JVI.01048-10","article-title":"Inhibition of the ubiquitin-proteasome system Affects influenza A virus infection at a postfusion step","volume":"84","author":"Widjaja","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crphar.2021.100058_bib121","first-page":"4","volume":"vol. 27","author":"Wong","year":"2020"},{"key":"10.1016\/j.crphar.2021.100058_bib122","first-page":"5447","article-title":"Maraviroc: a review of its use in HIV infection and beyond","volume":"9","author":"Woollard","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.crphar.2021.100058_bib123","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.crphar.2021.100058_bib124","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.crphar.2021.100058_bib125","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"The Lancet. Respiratory medicine"},{"key":"10.1016\/j.crphar.2021.100058_bib126","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.crphar.2021.100058_bib127","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-018-0034-1","article-title":"Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry","volume":"4","author":"Yang","year":"2018","journal-title":"Cell Discovery"},{"key":"10.1016\/j.crphar.2021.100058_bib128","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00226-17","article-title":"The toll-like receptor 4 antagonist eritoran protects mice from lethal filovirus challenge","volume":"8","author":"Younan","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.crphar.2021.100058_bib129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.antiviral.2015.09.008","article-title":"Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults","volume":"123","author":"Zenilman","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib130","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.02055-15","article-title":"C646, a novel p300\/CREB-binding protein-specific inhibitor of histone Acetyltransferase, attenuates influenza A virus infection","volume":"60","author":"Zhao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crphar.2021.100058_bib131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2011.07.014","article-title":"Aprotinin and similar protease inhibitors as drugs against influenza","volume":"92","author":"Zhirnov","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.crphar.2021.100058_bib132","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12250-018-0057-7","article-title":"Histone Deacetylase 3 inhibitor suppresses hepatitis C virus replication by regulating apo-A1 and LEAP-1 expression","volume":"33","author":"Zhou","year":"2018","journal-title":"Virol. Sin."},{"key":"10.1016\/j.crphar.2021.100058_bib133","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","volume":"395","author":"Zumla","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.crphar.2021.100058_bib134","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","article-title":"Host-directed therapies for infectious diseases: current status, recent progress, and future prospects","volume":"16","author":"Zumla","year":"2016","journal-title":"Lancet Infect. Dis."}],"container-title":["Current Research in Pharmacology and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257121000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257121000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:56:15Z","timestamp":1762923375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590257121000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":134,"alternative-id":["S2590257121000456"],"URL":"https:\/\/doi.org\/10.1016\/j.crphar.2021.100058","relation":{},"ISSN":["2590-2571"],"issn-type":[{"value":"2590-2571","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host directed therapies: COVID-19 and beyond","name":"articletitle","label":"Article Title"},{"value":"Current Research in Pharmacology and Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphar.2021.100058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100058"}}